Abstract:Background: Dysregulation of prostate stem cell antigen (PSCA) has been implicated in human cancers. Studies have reported that PSCA expression is generally high in prostate cancer, which correlates with a worse survival. PSCA is also highly expressed in bladder, ovarian, and pancreatic cancers. However, PSCA is expressed at low levels in gastric, gallbladder and oesophageal cancers. At present, the clinical significance, expression pattern and biological function of PSCA in gastric cancer (GC) are still unclear. Methods: Previously, we used cDNA microarray as a screening tool to compare GC tissues with its matched normal gastric mucosa tissues (MNGT), and obtained the differentially expressed genes of the two tissue types. PSCA is one of the genes significantly down-regulated in GC tissues. In this study, we detected the expression of PSCA in GC tissues and MNGT by western-blot experiment and immunohistochemical staining (IHC). Then the relationship between the expression pattern of PSCA and the clinicopathological characteristics and survival in GC was analyzed. In order to further study the function of PSCA in GC, lentivirus was used to construct stable cell lines with knockdown and overexpression of PSCA gene. We used AGS and MKN45 cell lines for plasmid transfection. Colony formation assay, MTS and nude mice xenograft model were performed to investigate the effect of PSCA in GC. Results: Western-blot and IHC assays demonstrated that the expression of PSCA in GC tissues was significantly lower than that in the MNGT. PSCA expression in GC tissues was high in 252 (57.5%) and low in 186 (42.5%) of 438 patients. PSCA expression for MNGT was high in 273 (62.3%) and low in 165 (37.7%) of 438 patients. PSCA expression was significantly associated with T classification (P=0.024), N classification (P=0.018) and TNM stage (P=0.019) using χ2 test. The relationship between PSCA expression level and patient survival was analysed using Kaplan-Meier analysis and the log-rank test. Low levels of PSCA expression were significantly associated with a poorer OS than high expression levels of PSCA (P=0.011). In the COX regression analysis of OS, all 9 variables in the univariate analysis were significantly correlated with OS (P<0.05), while the variables found to be independently correlated with OS in the multivariate analysis were PSCA expression (P=0.036), age (P<0.001), gender (P=0.007), and TNM stage (P<0.001), respectively. Univariate and multivariate analyses showed that PSCA was an independent prognostic factor for OS in GC. In vitro MTS cell proliferation experiment and clonal formation experiment and in vivo nude mouse subcutaneous tumorigenesis experiment all proved that knockdown of PSCA gene can improve the proliferation ability of GC cells, while in vitro experiment proved that overexpression of PSCA can reduce the proliferation ability of GC cells.It was found that knockdown of PSCA gene can improve the proliferation ability of GC cells both in vitro and in vivo, while overexpression of PSCA can reduce the proliferation ability of GC cells in vitro. Conclusion: Our study showed that the expression of PSCA gene was decreased in GC, which was related to more advanced pathological stages. And the expression level of PSCA in GC was an independent good prognostic factor. PSCA gene had the function of inhibiting GC proliferation.

The p300/CBP associated factor is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome.

Pcaf Acts As A Gastric Cancer Suppressor Through A Novel Pcaf-P16-Cdk4 Axis

Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancer

High Expression of PABPC1 Predicts Worse Survival of Gastric Cancer Patients

Downregulation of PSCA Promotes Gastric Cancer Proliferation and is Related to Poor Prognosis.

The prognostic impacts of PABPC1 expression on gastric cancer patients

Expression, Characteristics, and Clinical Target Prediction of PIK3C3/ vps34 in Gastric Cancer

LCP1 is a Prognostic Biomarker Correlated with Immune Infiltrates in Gastric Cancer.

Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.

PCDHGA10 as a potential prognostic biomarker and correlated with immune infiltration in gastric cancer

Pepsinogen C Interacts with IQGAP1 to Inhibit the Metastasis of Gastric Cancer Cells by Suppressing Rho-GTPase Pathway

[PCID2 is Highly Expressed in Gastric Cancer and Affects the Prognosis by Regulating Cancer Cell Cycle and Proliferation].

Expression of P53 and PCNA in gastric carcinoma detected by tissue microarray

Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments

Expression of P21(waf1/cip1) and P53 Proteins in Gastric Carcinoma: Its Relationships with Cell Proliferation Activity and Prognosis.

Analysis of PDL1 Expression and T Cells Infiltration in 1014 Gastric Cancer Patients.

Cip2a Is Overexpressed In Gastric Cancer And Its Depletion Leads To Impaired Clonogenicity, Senescence, Or Differentiation Of Tumor Cells

Paip1 Overexpression is Involved in the Progression of Gastric Cancer and Predicts Shorter Survival of Diagnosed Patients

Preliminary Study on the Inhibitory Effect of Tumor Suppressor Gene KPC1 on the Proliferation in Gastric Carcinoma Cell

The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients